VAERS reports by lot

GSK Varicella/Shingles lot 3NY5G: VAERS reports

65 VAERS reports list lot 3NY5G as a GSK Varicella/Shingles vaccine, received between 2018-09-13 and 2021-03-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
2%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8030%
Injection-site / Local reaction6524%
Dermatological (non-injection-site)2710%
Neurological218%
Allergic / Anaphylactic218%
Musculoskeletal218%
Cardiac / Cardiovascular166%
Gastrointestinal83%
Respiratory62%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
California6
Ohio6
Texas5
Arizona5
Pennsylvania3
North Carolina2
Illinois2
Maryland2
Missouri2
Arkansas2
New Jersey2

Reports by month received

2018-0932
2018-1017
2018-114
2018-121
2019-012
2019-022
2019-031
2019-042
2019-052
2021-011
2021-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.